HCMA Events
Photo Gallery
Hill Day 2025
HCMA goes to Capitol Hill to address issues with generic drug quality and Step Therapy.

HCMA Events

Ongoing research aims to better understand the genetic and molecular causes of Feline HCM. Clinical trials and studies on medications, like those adapted from human HCM treatments, are offering hope for new interventions. Collaborative efforts between veterinarians and researchers are crucial for breakthroughs.
Recent studies have identified genetic mutations in certain breeds, such as Maine Coons and Ragdolls, which predispose them to HCM. Research is also focusing on biomarkers that could enable earlier detection and intervention. Pharmaceutical advancements, including the adaptation of human drugs like mavacamten, show promise in reducing heart muscle thickening in feline patients.

Collaboration with leading academic institutions and veterinary schools is essential in advancing the understanding and treatment of Feline HCM. Universities with specialized cardiology programs play a key role in training the next generation of veterinarians and conducting groundbreaking research.
Through partnerships with veterinary experts and institutions, we aim to provide the highest level of care and bring innovative solutions to feline heart health. These collaborations drive the development of clinical trials and ensure that cats receive expert diagnostic and treatment options.
There are many ways to get involved with Feline HCM. We'd love to hear from you and have you on board!
PHONE: 973-983-7429
EMAIL: Support@4hcm.org
ADDRESS: 66 Ford Road, Suite 213B, Denville, NJ 07834
© All Rights Reserved Hypertrophic Cardiomyopathy Association
Website powered by Neon One